Cargando…
SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis
Recent studies suggest that SF3B1 might be related to poor prognosis in CLL, but the results remain controversial. This meta-analysis was performed to clarify the relationship between SF3B1 mutation and prognosis in patients with CLL. The relevant published reports were searched in PubMed, EMBASE, a...
Autores principales: | Zhang, Zhenghao, Chen, Shu, Chen, Shuang, Chen, Gang, Zhang, Rui, Li, Jinhua, Qu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642526/ https://www.ncbi.nlm.nih.gov/pubmed/29050251 http://dx.doi.org/10.18632/oncotarget.19455 |
Ejemplares similares
-
Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
por: Schwaederlé, M, et al.
Publicado: (2013) -
Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients
por: Sadria, Reza, et al.
Publicado: (2022) -
Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
por: Alimu, Xierenguli, et al.
Publicado: (2023) -
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia
por: Aptullahoglu, Erhan, et al.
Publicado: (2023) -
SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
por: López-Oreja, Irene, et al.
Publicado: (2023)